You just read:

Japan MHLW Grants Orphan Drug Designation to Axicabtagene Ciloleucel for Treatment of Certain Types of B-Cell Lymphoma

News provided by

Daiichi Sankyo Company, Limited

Oct 03, 2018, 10:00 ET